Reduction-sensitive hyaluronic acid nanoparticles for targeted intracellular delivery of doxorubicin

Gurusamy Saravanakumar, Jung Min Shin, Jae Hyung Park

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Scopus citations

Abstract

Reduction-sensitive, amphiphilic HA conjugates (HA-SS-DDTs) were synthesized using the facile thiol-exchange reaction, and evaluated their potential as the carrier for intracellular delivery of the hydrophobic anticancer drug, doxorubicin (DOX). The HA-SS-DDT conjugates formed self-assembled nanoparticles in aqueous conditions, and DOX was successfully encapsulated into the nanoparticles by an oil-in-water emulsion method. The release rate of DOX from the DOX-loaded HA-SS-DDT (HA-SS-DDT-DOX) nanoparticles was accelerated in the presence of 10 mM glutathione, mimicking the intracellular condition. The HA-SS-DDT-DOX nanoparticles were efficiently taken up by SCC7 cancer cells that over-express the HA receptor (CD44). These results suggest that the HA-SS-DDT nanoparticles have the promising potential as the carrier of DOX for cancer therapy.

Original languageEnglish
Title of host publicationTechnical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
Pages289-292
Number of pages4
StatePublished - 2013
EventNanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013 - Washington, DC, United States
Duration: 12 May 201316 May 2013

Publication series

NameTechnical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
Volume3

Conference

ConferenceNanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
Country/TerritoryUnited States
CityWashington, DC
Period12/05/1316/05/13

Keywords

  • Doxorubicin
  • Drug delivery
  • Hyaluronic acid nanoparticle
  • Reduction-sensitive

Fingerprint

Dive into the research topics of 'Reduction-sensitive hyaluronic acid nanoparticles for targeted intracellular delivery of doxorubicin'. Together they form a unique fingerprint.

Cite this